Seattle Angel Conference to win funding for your startup or learn how to angel invest logo

Artemend is poised to be the next evolution in early stage breast cancer treatment. A major medical center is interested in adding Artemend to help treat breast cancer in 5 states. We completed six years of clinical trials with a 92% nonrecurrence rate and a 98% patient satisfaction rate. Benefits include a single procedure, fast recovery, minimal side effects and lower cost. Over 210,000 women could benefit from this new treatment per year..

Seattle Angel Conference to win funding for your startup or learn how to angel invest logo
Seattle Angel Conference is a program to learn how to angel invest and for startup companies seeking funding. Seattle Angel Conference is a program of Mossy Ventures.
Sign up for our newsletter
Mossy Ventures angel investing group in Seattle, WA logo
Copyright © 2022 Mossy Ventures
Privacy PolicyWeb Design & SEO by Symphysis
linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram